What Happened?
Minnetonka, MN-based NeoChord Appointed David Chung as President and Chief Executive Officer
About the Company
NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).
About the Person
David Chung is President and Chief Executive Officer at NeoChord. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile